Search
Results: 1
Genetic Variation in Sodium‐glucose Cotransporter 2 and Heart Failure
Julius L. Katzmann, Amy M. Mason, Winfried März, Marcus E. Kleber, Alexander Niessner, Matthias Blüher, Thimoteus Speer, Ulrich Laufs
Jun 21, 2021
Inhibition of sodium‐glucose cotransporter 2 (SGLT2) represents an emerging pharmaceutical approach for the treatment of heart failure. The mechanisms by which SGLT2 inhibitors reduce the risk of heart failure are not well...
Published by: Clinical Pharmacology & Therapeutics